Addition of Glitazone to Chemo May Help Treat CML
Combining glitazones with standard treatment improved survival in small study
Type 2 Diabetes Linked to More Alzheimer’s Neuropathology
Effect may be driven by tau phosphorylation, researchers say
Finerenone Linked to Improved UACR in Diabetic Nephropathy
Addition of finerenone to ACE inhibitor or ARB tied to reduction in urinary albumin-creatinine ratio
Many Teens With Chronic Illnesses Use Alcohol, Marijuana
Four out of 10 high school students with medical conditions used one or both in past year
August 2015 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for August 2015. This roundup includes...
CDC: Smoking Rate Falls to 15.2 Percent in the United States
Higher tobacco taxes, tough messages contributing to decline
Periodontal Disease Predicts CAC Progression in Type 1 Diabetes
No link with coronary artery calcium progression for individuals without diabetes
Nonalbuminuric CKD Ups Cardiovascular Morbidity in T1DM
Also linked to increase in all-cause mortality, but not albuminuria or end-stage renal disease
Osteonecrosis of Jaw Risk Highest for IV Bisphosphonate Use
High risk for zoledronate, denosumab mainly in prevention of skeletal-related events
FDA Warns of Joint Pain Tied to DPP-4 Inhibitors
Agency advises users with such symptoms to contact their doctor
